Your browser doesn't support javascript.
loading
Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease.
Yamamoto, Yumi; Kojima, Katsutoshi; Taura, Daisuke; Sone, Masakatsu; Washida, Kazuo; Egawa, Naohiro; Kondo, Takayuki; Minakawa, Eiko N; Tsukita, Kayoko; Enami, Takako; Tomimoto, Hidekazu; Mizuno, Toshiki; Kalaria, Raj N; Inagaki, Nobuya; Takahashi, Ryosuke; Harada-Shiba, Mariko; Ihara, Masafumi; Inoue, Haruhisa.
Afiliação
  • Yamamoto Y; Research Fellow of Japan Society for the Promotion of Science, Tokyo, Japan.
  • Kojima K; Department of Molecular Innovation in Lipidemiology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibeshinmachi, Suita-shi, Osaka, 564-0018, Japan.
  • Taura D; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Sone M; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Washida K; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. sonemasa@kuhp.kyoto-u.ac.jp.
  • Egawa N; Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi, Suita-shi, Osaka, 564-0018, Japan.
  • Kondo T; Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Minakawa EN; iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan.
  • Tsukita K; Department of Neurology, Kyoto University Graduate School of Medicine, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Enami T; Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Tomimoto H; iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan.
  • Mizuno T; Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan.
  • Kalaria RN; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8502, Japan.
  • Inagaki N; Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Takahashi R; iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan.
  • Harada-Shiba M; Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Ihara M; Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan.
  • Inoue H; Department of Dementia Prevention and Therapeutics, Graduate School of Medicine, Mie University, 2-174 Edobashi Tsu, Mie, 514-8507, Japan.
Mol Brain ; 13(1): 38, 2020 03 19.
Article em En | MEDLINE | ID: mdl-32188464
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas / Doenças de Pequenos Vasos Cerebrais / Modelos Biológicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Mol Brain Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas / Doenças de Pequenos Vasos Cerebrais / Modelos Biológicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Mol Brain Ano de publicação: 2020 Tipo de documento: Article